Improving Outcomes for Juvenile Idiopathic Arthritis

Children and parents often experience uncertainty and stress when juvenile idiopathic arthritis (JIA) is first diagnosed, which creates a need for structured support. Juvenile Idiopathic Support Program (JASP-1) provide patient-and family centered support during the first year after diagnosis. However, little is known about how a support program like JASP-1 can influence outcomes. Therefore, this study aimed to longitudinally examine registry data from children who participated in JASP 1 and to compare the outcomes with registry data from a matched control group.

NCT Number	NCT07659223
Lead Sponsor	Region Stockholm Collaborators: Karolinska University Hospital, Karolinska Institutet
Conditions	Juvenile Idiopahtic Arthritis
Enrollment	116 participants
Start Date	2019-08-15
Primary Completion	2026-02-19 (estimated)
Study Completion	2026-02-19 (estimated)
Updated on ClinicalTrials.gov	2026-06-22